Anaplastic Lymphoma Kinase (ALK)-positive Tumors (original) (raw)

Profile image of Rohan GuptaRohan Gupta

2019, American Journal of Clinical Oncology

visibility

description

9 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Translocations involving anaplastic lymphoma kinase (ALK)

Ren-Yuan Bai

Oncogene, 2001

View PDFchevron_right

The anaplastic lymphoma kinase in the pathogenesis of cancer

Roberto Piva

2008

View PDFchevron_right

Leukemias, myeloma, and other lymphoreticular neoplasms

Jose Luis Maciel Hernandez

Cancer, 1995

View PDFchevron_right

Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma

Georges Delsol

The American Journal of Pathology, 2000

View PDFchevron_right

Clinical achievements of the EORTC Lymphoma Group and

Paul Meijnders

2012

View PDFchevron_right

This is a call to oncologists for action

Miriam Lobo

Clinical & Translational Oncology, 2018

View PDFchevron_right

Introduction to Volume 3 Issue 3 in Archives in Cancer Research

Karel Petrak

Archives in Cancer Research, 2015

View PDFchevron_right

Cancer chemoprevention

Lynne Howells

European Journal of Cancer Prevention, 2014

View PDFchevron_right

A patient journey: Lymphangioleiomyomatosis

Havi Carel

View PDFchevron_right

International Journal of Cancer Therapy and Oncology

Alia Attia

2016

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Current Clinical Oncology TM

Richard Pestell

2008

View PDFchevron_right

Endobronchial non-Hodgkin's lymphoma*

Mauro Zamboni

2003

View PDFchevron_right

Crossreacting human lymphoma idiotypes

Ronald Delellis

2000

View PDFchevron_right

Hodgkin′s lymphoma of the breast

cornelius ukah

Journal of Cancer Research and Therapeutics, 2013

View PDFchevron_right

Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer

Rommel Burbano

Pharmaceutics, 2022

View PDFchevron_right

Tumores presacros. Análisis de nuestra experiencia en 20 casos tratados quirúrgicamente

Vicente Pla

Cirugía Española, 2010

View PDFchevron_right

Recent Progress in Cancer Research

Abdenbi Khalqallah

Association of Schools of Public Health, 1953

View PDFchevron_right

Protein Kinase A in Cancer

Carla Mucignat

View PDFchevron_right

Highlights from: the 45th Annual Meeting of the American Society of Clinical Oncology Orlando, FL; May 29 – June 2, 2009

Timothy Quill

Clinical Colorectal Cancer, 2009

View PDFchevron_right

Lymphoma Prevalence Patterns in

Adriane Kamulegeya

2013

View PDFchevron_right

Abdominal lymphangioma

JK Banerjee

Medical Journal Armed Forces India, 2016

View PDFchevron_right

Aspects of cancer immunotherapy

Bruce Loveland

Immunology and Cell Biology, 2003

View PDFchevron_right

A major turning point in NK/T-cell lymphoma?

Olivier Hermine

Blood, 2017

View PDFchevron_right

Requirement for CDK4 kinase function in breast cancer

Humphrey Gardner

Cancer Cell, 2006

View PDFchevron_right

Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors

ahmet yassa

Lung Cancer: Targets and Therapy, 2020

View PDFchevron_right

ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum

Georges Delsol

The American Journal of Pathology, 1998

View PDFchevron_right

Molecular insight into the diagnosis of lymphoma

Mariastefania Antica

International Journal of Molecular Medicine, 2003

View PDFchevron_right

ACR Appropriateness Criteria®: Follow-Up of Hodgkin's Lymphoma

Chul Ha

Current Problems in Cancer, 2010

View PDFchevron_right

Disseminated high-grade malignant lymphoma involving both breasts

Ozlem Er Civelek

The Breast, 2002

View PDFchevron_right

Clinico-Pathologic Conference AAOMP/IAOP 2008: Case 3

Sani Bello

Head and Neck Pathology, 2008

View PDFchevron_right

Second malignant neoplasms after treatment of childhood cancer

Naomi Winick

European Journal of Cancer, 2003

View PDFchevron_right

Aberrant ALK Tyrosine Kinase Signaling

Marc Ladanyi

The American Journal of Pathology, 2000

View PDFchevron_right

Recent progress in cancer therapeutics

Michael Rossbach

Translational oncology, 2009

View PDFchevron_right

ALK Gene Rearrangemnet in Lung Adenocarcinoma

Fnu Raja

Pakistan Armed Forces Medical Journal, 2023

View PDFchevron_right

Emergence of new ALK mutations at relapse of neuroblastoma

Ingrid Øra

2014

View PDFchevron_right

DentistryMetastasisMedicineAnaplastic Lymphoma Kinase (ALK)Pleural EffusionKRAS